Published in Structure on July 15, 1995
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A (1997) 6.92
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol (2002) 2.93
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol (2001) 1.91
Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol (1997) 1.88
Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother (1999) 1.83
Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A (2009) 1.71
A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J Virol (1997) 1.63
Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J Virol (2001) 1.46
Cold-adapted poliovirus mutants bypass a postentry replication block. J Virol (1997) 1.42
Viral calciomics: interplays between Ca2+ and virus. Cell Calcium (2009) 1.33
Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J Virol (2013) 1.32
Complexes of poliovirus serotypes with their common cellular receptor, CD155. J Virol (2003) 1.31
Molecular dynamics simulations of human rhinovirus and an antiviral compound. Biophys J (2001) 1.22
Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol (2001) 1.20
5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol (2005) 1.19
SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17
Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex. Proc Natl Acad Sci U S A (2002) 1.17
Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol (2003) 1.16
Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J Virol (1999) 1.14
Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region. J Virol (2000) 1.14
Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science (2015) 1.14
Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol (2005) 1.13
Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob Agents Chemother (2004) 1.12
Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis. J Virol (2003) 1.07
Interaction of decay-accelerating factor with coxsackievirus B3. J Virol (2007) 1.04
Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection. J Virol (2002) 1.03
5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology (2008) 1.02
Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3. J Virol (2004) 0.99
Interaction of decay-accelerating factor with echovirus 7. J Virol (2010) 0.98
Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A (2013) 0.98
Characterization of a putative ancestor of coxsackievirus B5. J Virol (2010) 0.96
Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid. Proc Natl Acad Sci U S A (2005) 0.96
Expression of an antigenic adenovirus epitope in a group B coxsackievirus. J Virol (2000) 0.96
Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J Virol (1997) 0.95
Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle. J Virol (2014) 0.94
Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain. J Clin Microbiol (2000) 0.93
Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule. J Virol (2004) 0.93
Genetic diversity of human enterovirus 68 strains isolated in Kenya using the hypervariable 3'-end of VP1 gene. PLoS One (2014) 0.93
Mutation of predicted virion pit residues alters binding of Theiler's murine encephalomyelitis virus to BHK-21 cells. J Virol (2000) 0.93
Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon. J Virol (2005) 0.93
Natural recombination event within the capsid genomic region leading to a chimeric strain of human enterovirus B. J Virol (2007) 0.93
N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J Virol (2006) 0.91
Picornavirus uncoating. Mol Pathol (2002) 0.91
An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain. Proc Natl Acad Sci U S A (2006) 0.91
Crystal structure of Swine vesicular disease virus and implications for host adaptation. J Virol (2003) 0.90
Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure. J Mol Evol (1998) 0.90
Molecular determinants of disease in coxsackievirus B1 murine infection. J Med Virol (2011) 0.86
Structure determination of enterovirus 71. Acta Crystallogr D Biol Crystallogr (2012) 0.86
A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. J Virol (2010) 0.85
Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21. J Virol (2004) 0.84
Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes. Med Microbiol Immunol (2003) 0.83
Coxsackievirus B3-induced cellular protrusions: structural characteristics and functional competence. J Virol (2011) 0.82
Rhodanine resistance and dependence of echovirus 12: a possible consequence of capsid flexibility. J Virol (1997) 0.81
Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection. J Virol (2004) 0.81
Phylogenetic patterns of human coxsackievirus B5 arise from population dynamics between two genogroups and reveal evolutionary factors of molecular adaptation and transmission. J Virol (2013) 0.81
Virucidal efficacy of glutaraldehyde against enteroviruses is related to the location of lysine residues in exposed structures of the VP1 capsid protein. Appl Environ Microbiol (2004) 0.80
Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivity. J Virol (2001) 0.80
Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity. J Virol (2007) 0.80
Structure of swine vesicular disease virus: mapping of changes occurring during adaptation of human coxsackie B5 virus to infect swine. J Virol (2003) 0.80
Binding of glutathione to enterovirus capsids is essential for virion morphogenesis. PLoS Pathog (2014) 0.79
The novel asymmetric entry intermediate of a picornavirus captured with nanodiscs. Sci Adv (2016) 0.79
Fatty acid-depleted albumin induces the formation of echovirus A particles. J Virol (2000) 0.79
Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1. Virology (2007) 0.78
Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line. J Biomed Sci (2014) 0.77
Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants. Vaccine (2012) 0.77
Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy. J Virol (2003) 0.77
Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses. ChemMedChem (2015) 0.76
Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3. MBio (2016) 0.76
Coxsackievirus B3 infection and its mutation in Keshan disease. World J Gastroenterol (2004) 0.75
Crystallography, evolution, and the structure of viruses. J Biol Chem (2012) 0.75
Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin. Sci Rep (2016) 0.75
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
Chemical and biological evolution of nucleotide-binding protein. Nature (1974) 7.39
Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer (1999) 6.86
X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58
The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol (1980) 6.24
Structure of the bacteriophage phi29 DNA packaging motor. Nature (2000) 5.25
Comparison of super-secondary structures in proteins. J Mol Biol (1973) 4.85
Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J Gen Virol (1983) 4.45
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40
The atomic structure of Mengo virus at 3.0 A resolution. Science (1987) 4.34
Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature (1991) 4.24
Rotation function calculations with GLRF program. Methods Enzymol (1997) 3.99
Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol (1996) 3.93
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77
Determining the intensity of Bragg reflections from oscillation photographs. Methods Enzymol (1985) 3.72
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci U S A (1993) 3.62
Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci U S A (1987) 2.99
Assembly of a tailed bacterial virus and its genome release studied in three dimensions. Cell (1998) 2.91
The locked rotation function. Acta Crystallogr A (1990) 2.65
Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J Virol (1989) 2.61
Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol (1989) 2.49
Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure (1996) 2.46
Atomic structure of single-stranded DNA bacteriophage phi X174 and its functional implications. Nature (1992) 2.44
Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A (2000) 2.42
Structure of beef liver catalase. J Mol Biol (1981) 2.35
Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc Natl Acad Sci U S A (1988) 2.30
Structural constraints of possible mechanisms of lactate dehydrogenase as shown by high resolution studies of the apoenzyme and a variety of enzyme complexes. Cold Spring Harb Symp Quant Biol (1972) 2.23
Exploring structural homology of proteins. J Mol Biol (1976) 2.23
Protein folding. Annu Rev Biochem (1981) 2.21
Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J (1999) 2.17
Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure (1998) 2.17
Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci (1982) 2.14
Structure, sequence, and function correlations among parvoviruses. Virology (1993) 2.06
Structure and morphogenesis of bacteriophage T4. Cell Mol Life Sci (2003) 2.06
Studies of asymmetry in the three-dimensional structure of lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1975) 2.05
Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res (1992) 2.03
Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J Gen Virol (1979) 2.01
A collagen disorder of the nervous system presenting as multiple sclerosis. Brain (1972) 2.00
Structure and assembly of large lipid-containing dsDNA viruses. Nat Struct Biol (2000) 2.00
Structure determination of feline panleukopenia virus empty particles. Proteins (1993) 1.99
Refined crystal structure of dogfish M4 apo-lactate dehydrogenase. J Mol Biol (1987) 1.98
The active center of catalase. J Mol Biol (1985) 1.97
Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology (1978) 1.93
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J Virol (1989) 1.92
Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol (2001) 1.91
Structural adaptations of lactate dehydrogenase isozymes. Proc Natl Acad Sci U S A (1977) 1.88
Structure-function relationships in lactate dehydrogenase. Proc Natl Acad Sci U S A (1973) 1.87
Structure of a viral procapsid with molecular scaffolding. Nature (1997) 1.85
The structure of human rhinovirus 16. Structure (1993) 1.83
Structure and self-association of the Rous sarcoma virus capsid protein. Structure (2000) 1.83
The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure (1997) 1.82
Climate change and the integrity of science. Science (2010) 1.80
Structure of lactate dehydrogenase at 2-8 A resolution. Nature (1970) 1.78
Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A. J Mol Biol (1990) 1.78
Structure of southern bean mosaic virus at 2.8 A resolution. Nature (1980) 1.78
The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2. J Virol (1985) 1.74
Structure determination of the head-tail connector of bacteriophage phi29. Acta Crystallogr D Biol Crystallogr (2001) 1.74
A comparison of the heme binding pocket in globins and cytochrome b5. J Biol Chem (1975) 1.74
The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci U S A (1998) 1.73
Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain. Structure (1997) 1.72
Structure of Semliki Forest virus core protein. Proteins (1997) 1.70
Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections. J Exp Med (1982) 1.69
Analysis of the single-stranded DNA bacteriophage phi X174, refined at a resolution of 3.0 A. J Mol Biol (1994) 1.66
Epidemiology of single and multiple species of helminth infections among school children in Busia District, Kenya. East Afr Med J (2000) 1.62
The taxonomy of protein structure. J Mol Biol (1977) 1.61
Connexin43 null mice reveal that astrocytes express multiple connexins. Brain Res Brain Res Rev (2000) 1.61
Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet (1999) 1.59
Structure determination of crystalline lobster D-glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol (1974) 1.57
The clinical impact of warmed insufflation carbon dioxide gas for laparoscopic cholecystectomy. Surg Endosc (2000) 1.55
Cryoelectron-microscopy image reconstruction of symmetry mismatches in bacteriophage phi29. J Struct Biol (2001) 1.54
The NADPH binding site on beef liver catalase. Proc Natl Acad Sci U S A (1985) 1.54
The role of scaffolding proteins in the assembly of the small, single-stranded DNA virus phiX174. J Mol Biol (1999) 1.52
Refined structure of Sindbis virus core protein and comparison with other chymotrypsin-like serine proteinase structures. J Mol Biol (1993) 1.49
The structure of an insect parvovirus (Galleria mellonella densovirus) at 3.7 A resolution. Structure (1998) 1.48
Preliminary X-ray crystallographic analysis of canine parvovirus crystals. J Mol Biol (1988) 1.46
[Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery]. Chirurg (2008) 1.44
Perspectives on stimulating industrial research and development for neglected infectious diseases. Bull World Health Organ (2001) 1.44
Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol (2009) 1.43
Human rhinovirus 3 at 3.0 A resolution. Structure (1996) 1.42
Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Annu Rev Microbiol (1992) 1.41
Crystallographic studies on lactate dehydrogenase at-75 degrees C. Acta Crystallogr B (1970) 1.40
The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis. Leukemia (2006) 1.40
Similarities in active center geometries of zinc-containing enzymes, proteases and dehydrogenases. J Mol Biol (1978) 1.40
Molecular diagnosis of a Mycobacterium chelonae infection. Pathol Res Pract (2001) 1.39
The structure of human parvovirus B19 at 8 A resolution. Virology (1994) 1.38
Structure of the active ternary complex of pig heart lactate dehydrogenase with S-lac-NAD at 2.7 A resolution. J Mol Biol (1981) 1.38
Human rhinovirus 14 complexed with antiviral compound R 61837. J Mol Biol (1991) 1.38